Mao Y, Schwarzbauer JE (2005). „Fibronectin fibrillogenesis, a cell-mediated matrix assembly process”. Matrix biology : journal of the International Society for Matrix Biology. 24 (6): 389—99. PMID16061370. doi:10.1016/j.matbio.2005.06.008.
Erickson, H. P. (2002). „Stretching fibronectin”. Journal of muscle research and cell motility. 23 (5-6): 575—80. PMID12785106. doi:10.1023/A:1023427026818.
Valenick LV, Hsia HC, Schwarzbauer JE (2005). „Fibronectin fragmentation promotes alpha4beta1 integrin-mediated contraction of a fibrin-fibronectin provisional matrix”. Experimental cell research. 309 (1): 48—55. PMID15992798. doi:10.1016/j.yexcr.2005.05.024.
Wierzbicka-Patynowski I, Schwarzbauer JE (2003). „The ins and outs of fibronectin matrix assembly”. Journal of cell science. 116 (Pt 16): 3269—76. PMID12857786. doi:10.1242/jcs.00670.
Han S, Khuri FR, Roman J (2006). „Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways”. Cancer research. 66 (1): 315—23. PMID16397245. doi:10.1158/0008-5472.CAN-05-2367.
Chen M, Marinkovich MP, Veis A, Cai X, Rao CN, O'Toole EA, Woodley DT (1997). „Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin”. J. Biol. Chem. UNITED STATES. 272 (23): 14516—22. ISSN0021-9258. PMID9169408. doi:10.1074/jbc.272.23.14516.
Chung, C Y; Zardi, L.; Erickson H P (1995). „Binding of tenascin-C to soluble fibronectin and matrix fibrils”. J. Biol. Chem. UNITED STATES. 270 (48): 29012—7. ISSN0021-9258. PMID7499434. doi:10.1074/jbc.270.48.29012.
Martin, J A; Miller B A; et al. (2002). „Co-localization of insulin-like growth factor binding protein 3 and fibronectin in human articular cartilage”. Osteoarthr. Cartil. England. 10 (7): 556—63. ISSN1063-4584. PMID12127836. doi:10.1053/joca.2002.0791.
Gui, Y; Murphy L J (2001). „Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma”. J. Clin. Endocrinol. Metab. United States. 86 (5): 2104—10. ISSN0021-972X. PMID11344214. doi:10.1210/jc.86.5.2104.
Mao Y, Schwarzbauer JE (2005). „Fibronectin fibrillogenesis, a cell-mediated matrix assembly process”. Matrix biology : journal of the International Society for Matrix Biology. 24 (6): 389—99. PMID16061370. doi:10.1016/j.matbio.2005.06.008.
Erickson, H. P. (2002). „Stretching fibronectin”. Journal of muscle research and cell motility. 23 (5-6): 575—80. PMID12785106. doi:10.1023/A:1023427026818.
Wierzbicka-Patynowski I, Schwarzbauer JE (2003). „The ins and outs of fibronectin matrix assembly”. Journal of cell science. 116 (Pt 16): 3269—76. PMID12857786. doi:10.1242/jcs.00670.
Han S, Khuri FR, Roman J (2006). „Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways”. Cancer research. 66 (1): 315—23. PMID16397245. doi:10.1158/0008-5472.CAN-05-2367.
Chen M, Marinkovich MP, Veis A, Cai X, Rao CN, O'Toole EA, Woodley DT (1997). „Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin”. J. Biol. Chem. UNITED STATES. 272 (23): 14516—22. ISSN0021-9258. PMID9169408. doi:10.1074/jbc.272.23.14516.
Chung, C Y; Zardi, L.; Erickson H P (1995). „Binding of tenascin-C to soluble fibronectin and matrix fibrils”. J. Biol. Chem. UNITED STATES. 270 (48): 29012—7. ISSN0021-9258. PMID7499434. doi:10.1074/jbc.270.48.29012.
Martin, J A; Miller B A; et al. (2002). „Co-localization of insulin-like growth factor binding protein 3 and fibronectin in human articular cartilage”. Osteoarthr. Cartil. England. 10 (7): 556—63. ISSN1063-4584. PMID12127836. doi:10.1053/joca.2002.0791.
Gui, Y; Murphy L J (2001). „Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma”. J. Clin. Endocrinol. Metab. United States. 86 (5): 2104—10. ISSN0021-972X. PMID11344214. doi:10.1210/jc.86.5.2104.
Chen M, Marinkovich MP, Veis A, Cai X, Rao CN, O'Toole EA, Woodley DT (1997). „Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin”. J. Biol. Chem. UNITED STATES. 272 (23): 14516—22. ISSN0021-9258. PMID9169408. doi:10.1074/jbc.272.23.14516.
Chung, C Y; Zardi, L.; Erickson H P (1995). „Binding of tenascin-C to soluble fibronectin and matrix fibrils”. J. Biol. Chem. UNITED STATES. 270 (48): 29012—7. ISSN0021-9258. PMID7499434. doi:10.1074/jbc.270.48.29012.
Martin, J A; Miller B A; et al. (2002). „Co-localization of insulin-like growth factor binding protein 3 and fibronectin in human articular cartilage”. Osteoarthr. Cartil. England. 10 (7): 556—63. ISSN1063-4584. PMID12127836. doi:10.1053/joca.2002.0791.
Gui, Y; Murphy L J (2001). „Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma”. J. Clin. Endocrinol. Metab. United States. 86 (5): 2104—10. ISSN0021-972X. PMID11344214. doi:10.1210/jc.86.5.2104.